Michael Parini

Chief Legal Officer · Biogen

Biotechnology

Michael Parini is Biogen’s chief legal officer, following the CEO role at Spur Therapeutics and senior legal and operating leadership at Vertex and Pfizer.

Last reviewed: Nov 2, 2026

Michael Parini

Chief Legal Officer
Biogen

Last Reviewed: November 2, 2026

Executive Summary

Michael Parini is Biogen’s chief legal officer, following the CEO role at Spur Therapeutics and senior legal and operating leadership at Vertex and Pfizer.

Career Highlights

  • Became Biogen chief legal officer on August 3, 2026.
  • Joined Freeline Therapeutics as president and COO in March 2021 and became CEO that August.
  • Previously oversaw legal, administrative and business development functions at Vertex.

Professional Journey

Parini held several senior legal positions at Pfizer, including chief litigation counsel. He subsequently moved to Vertex Pharmaceuticals, where he rose to chief administrative, legal and business development officer and served on the executive committee.

His Vertex remit extended beyond legal and compliance to business development, human resources, information technology, quality and corporate communications. He helped lead the acquisitions of Exonics Therapeutics and Semma Therapeutics and negotiations over access to cystic fibrosis medicines in the United Kingdom, France, Italy, Australia and Spain.

In March 2021, Parini joined Freeline Therapeutics as president and chief operating officer. Freeline appointed him CEO and executive director on August 16, 2021. He later led the business as Spur Therapeutics, where he redefined its scientific strategy and advanced a rare disease program from preclinical research into Phase 3 development.

Parini became Biogen’s chief legal officer on August 3, 2026, joining its executive committee and taking responsibility for global legal and compliance functions.

Education

Parini holds a B.A. in American government and politics from Georgetown University and a J.D. from Georgetown University Law Center.